Ionis Pharmaceuticals IONS Amortization of capitalized software and acquired intangible assets
Amortization of capitalized software and acquired intangible assets at other companies
Other financials
Where this comes from
Reported directly by Ionis Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:AmortizationOfIntangibleAssets.
The official record: Ionis Pharmaceuticals’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ionis Pharmaceuticals's amortization of capitalized software and acquired intangible assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ionis Pharmaceuticals's amortization of capitalized software and acquired intangible assets?
- Ionis Pharmaceuticals (IONS) reported amortization of capitalized software and acquired intangible assets of $661K in Q1 2026.
- How has Ionis Pharmaceuticals's amortization of capitalized software and acquired intangible assets changed year-over-year?
- Ionis Pharmaceuticals's amortization of capitalized software and acquired intangible assets increased by 13.6% year-over-year, from $582K to $661K.
- What is the long-term trend for Ionis Pharmaceuticals's amortization of capitalized software and acquired intangible assets?
- Over 4 years (2021 to 2025), Ionis Pharmaceuticals's amortization of capitalized software and acquired intangible assets has grown at a 0.9% compound annual growth rate (CAGR), from $2.35M to $2.44M.